zepbound is a semaglutide Zepbound: The newest obesity medication explained by an expert Zepbound outperforms Ozempic and Wegovy

Melatonin protects the brain from apoptosis by enhancement of autophagy after traumatic brain injury in mice

Genetic Factors That Influence Your Optimal Injection Timing Your GLP1R gene variant (rs6923761) affects how efficiently your receptors respond to semaglutide, and this sensitivity may interact with circadian timing

J Pharmacol Exp Ther 302 : 822827 Cowley MA et al

It may also increase appetite and lead to poor food decisions

Clinical Evidence: Semaglutide and Cholesterol Trial Results The SUSTAIN-6 trial, which followed over 3,000 patients on semaglutide, documented significant reductions in LDL cholesterol alongside weight loss and improved glycemic control

[2] The second part of the ESSENCE trial will extend to 240 weeks, focusing on whether semaglutide lowers the risk of liver-related clinical events compared with placebo.1 Findings are expected to read out in 2029